SMAD3 and breast carcinoma: The overexpression of SMAD3 in a breast cancer cell line has been shown to cause cell cycle arrest [31], while in SMAD3−/− mammary epithelial cells, both TGF-beta-induced growth inhibition and apoptosis are lost [32].